Serveur d'exploration sur la grippe en Espagne

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the Global Influenza Hospital Surveillance Network.

Identifieur interne : 000138 ( Main/Exploration ); précédent : 000137; suivant : 000139

Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the Global Influenza Hospital Surveillance Network.

Auteurs : Joan Puig-Barberà [Espagne] ; Elena Burtseva [Russie] ; Hongjie Yu [République populaire de Chine] ; Benjamin J. Cowling [République populaire de Chine] ; Selim Badur [Turquie] ; Jan Kyncl [République tchèque] ; Anna Sominina [Russie]

Source :

RBID : pubmed:27556802

Descripteurs français

English descriptors

Abstract

The Global Influenza Hospital Surveillance Network (GIHSN) has established a prospective, active surveillance, hospital-based epidemiological study to collect epidemiological and virological data for the Northern and Southern Hemispheres over several consecutive seasons. It focuses exclusively on severe cases of influenza requiring hospitalization. A standard protocol is shared between sites allowing comparison and pooling of results. During the 2014-2015 influenza season, the GIHSN included seven coordinating sites from six countries (St. Petersburg and Moscow, Russian Federation; Prague, Czech Republic; Istanbul, Turkey; Beijing, China; Valencia, Spain; and Rio de Janeiro, Brazil). Here, we present the detailed epidemiological and influenza vaccine effectiveness findings for the Northern Hemisphere 2014-2015 influenza season.

DOI: 10.1186/s12889-016-3378-1
PubMed: 27556802
PubMed Central: PMC5001209


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the Global Influenza Hospital Surveillance Network.</title>
<author>
<name sortKey="Puig Barbera, Joan" sort="Puig Barbera, Joan" uniqKey="Puig Barbera J" first="Joan" last="Puig-Barberà">Joan Puig-Barberà</name>
<affiliation wicri:level="1">
<nlm:affiliation>Foundation for the Promotion of Health and Biomedical Research in the Valencia Region FISABIO - Public Health, Avda Catalunya 21, 46020, Valencia, Spain. puig_joa@gva.es.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Foundation for the Promotion of Health and Biomedical Research in the Valencia Region FISABIO - Public Health, Avda Catalunya 21, 46020, Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Burtseva, Elena" sort="Burtseva, Elena" uniqKey="Burtseva E" first="Elena" last="Burtseva">Elena Burtseva</name>
<affiliation wicri:level="1">
<nlm:affiliation>D.I. Ivanovsky Institute of Virology FGBC "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation, Russia.</nlm:affiliation>
<country xml:lang="fr">Russie</country>
<wicri:regionArea>D.I. Ivanovsky Institute of Virology FGBC "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation</wicri:regionArea>
<wicri:noRegion>Russian Federation</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yu, Hongjie" sort="Yu, Hongjie" uniqKey="Yu H" first="Hongjie" last="Yu">Hongjie Yu</name>
<affiliation wicri:level="3">
<nlm:affiliation>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Cowling, Benjamin J" sort="Cowling, Benjamin J" uniqKey="Cowling B" first="Benjamin J" last="Cowling">Benjamin J. Cowling</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Special Administrative Region, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Special Administrative Region</wicri:regionArea>
<wicri:noRegion>Special Administrative Region</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Badur, Selim" sort="Badur, Selim" uniqKey="Badur S" first="Selim" last="Badur">Selim Badur</name>
<affiliation wicri:level="1">
<nlm:affiliation>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kyncl, Jan" sort="Kyncl, Jan" uniqKey="Kyncl J" first="Jan" last="Kyncl">Jan Kyncl</name>
<affiliation wicri:level="3">
<nlm:affiliation>National Institute of Public Health (NIPH), Prague, Czech Republic.</nlm:affiliation>
<country xml:lang="fr">République tchèque</country>
<wicri:regionArea>National Institute of Public Health (NIPH), Prague</wicri:regionArea>
<placeName>
<settlement type="city">Prague</settlement>
<region type="région" nuts="2">Bohême centrale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sominina, Anna" sort="Sominina, Anna" uniqKey="Sominina A" first="Anna" last="Sominina">Anna Sominina</name>
<affiliation wicri:level="1">
<nlm:affiliation>Research Institute of Influenza, Saint Petersburg, Russian Federation, Russia.</nlm:affiliation>
<country xml:lang="fr">Russie</country>
<wicri:regionArea>Research Institute of Influenza, Saint Petersburg, Russian Federation</wicri:regionArea>
<wicri:noRegion>Russian Federation</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27556802</idno>
<idno type="pmid">27556802</idno>
<idno type="doi">10.1186/s12889-016-3378-1</idno>
<idno type="pmc">PMC5001209</idno>
<idno type="wicri:Area/Main/Corpus">00122</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00122</idno>
<idno type="wicri:Area/Main/Curation">000122</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000122</idno>
<idno type="wicri:Area/Main/Exploration">000122</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the Global Influenza Hospital Surveillance Network.</title>
<author>
<name sortKey="Puig Barbera, Joan" sort="Puig Barbera, Joan" uniqKey="Puig Barbera J" first="Joan" last="Puig-Barberà">Joan Puig-Barberà</name>
<affiliation wicri:level="1">
<nlm:affiliation>Foundation for the Promotion of Health and Biomedical Research in the Valencia Region FISABIO - Public Health, Avda Catalunya 21, 46020, Valencia, Spain. puig_joa@gva.es.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Foundation for the Promotion of Health and Biomedical Research in the Valencia Region FISABIO - Public Health, Avda Catalunya 21, 46020, Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Burtseva, Elena" sort="Burtseva, Elena" uniqKey="Burtseva E" first="Elena" last="Burtseva">Elena Burtseva</name>
<affiliation wicri:level="1">
<nlm:affiliation>D.I. Ivanovsky Institute of Virology FGBC "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation, Russia.</nlm:affiliation>
<country xml:lang="fr">Russie</country>
<wicri:regionArea>D.I. Ivanovsky Institute of Virology FGBC "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation</wicri:regionArea>
<wicri:noRegion>Russian Federation</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yu, Hongjie" sort="Yu, Hongjie" uniqKey="Yu H" first="Hongjie" last="Yu">Hongjie Yu</name>
<affiliation wicri:level="3">
<nlm:affiliation>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Cowling, Benjamin J" sort="Cowling, Benjamin J" uniqKey="Cowling B" first="Benjamin J" last="Cowling">Benjamin J. Cowling</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Special Administrative Region, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Special Administrative Region</wicri:regionArea>
<wicri:noRegion>Special Administrative Region</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Badur, Selim" sort="Badur, Selim" uniqKey="Badur S" first="Selim" last="Badur">Selim Badur</name>
<affiliation wicri:level="1">
<nlm:affiliation>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kyncl, Jan" sort="Kyncl, Jan" uniqKey="Kyncl J" first="Jan" last="Kyncl">Jan Kyncl</name>
<affiliation wicri:level="3">
<nlm:affiliation>National Institute of Public Health (NIPH), Prague, Czech Republic.</nlm:affiliation>
<country xml:lang="fr">République tchèque</country>
<wicri:regionArea>National Institute of Public Health (NIPH), Prague</wicri:regionArea>
<placeName>
<settlement type="city">Prague</settlement>
<region type="région" nuts="2">Bohême centrale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sominina, Anna" sort="Sominina, Anna" uniqKey="Sominina A" first="Anna" last="Sominina">Anna Sominina</name>
<affiliation wicri:level="1">
<nlm:affiliation>Research Institute of Influenza, Saint Petersburg, Russian Federation, Russia.</nlm:affiliation>
<country xml:lang="fr">Russie</country>
<wicri:regionArea>Research Institute of Influenza, Saint Petersburg, Russian Federation</wicri:regionArea>
<wicri:noRegion>Russian Federation</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">BMC public health</title>
<idno type="eISSN">1471-2458</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Brazil (epidemiology)</term>
<term>Child (MeSH)</term>
<term>Child, Preschool (MeSH)</term>
<term>China (epidemiology)</term>
<term>Czech Republic (epidemiology)</term>
<term>Female (MeSH)</term>
<term>Hospitalization (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Infant (MeSH)</term>
<term>Infant, Newborn (MeSH)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Population Surveillance (MeSH)</term>
<term>Prospective Studies (MeSH)</term>
<term>Russia (epidemiology)</term>
<term>Seasons (MeSH)</term>
<term>Spain (epidemiology)</term>
<term>Turkey (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Brésil (épidémiologie)</term>
<term>Chine (épidémiologie)</term>
<term>Enfant (MeSH)</term>
<term>Enfant d'âge préscolaire (MeSH)</term>
<term>Espagne (épidémiologie)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (prévention et contrôle)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Hospitalisation (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Nourrisson (MeSH)</term>
<term>Nouveau-né (MeSH)</term>
<term>Russie (épidémiologie)</term>
<term>République tchèque (épidémiologie)</term>
<term>Saisons (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
<term>Surveillance de la population (MeSH)</term>
<term>Turquie (épidémiologie)</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Études prospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Brazil</term>
<term>China</term>
<term>Czech Republic</term>
<term>Influenza, Human</term>
<term>Russia</term>
<term>Spain</term>
<term>Turkey</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Brésil</term>
<term>Chine</term>
<term>Espagne</term>
<term>Grippe humaine</term>
<term>Russie</term>
<term>République tchèque</term>
<term>Turquie</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Hospitalization</term>
<term>Humans</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Population Surveillance</term>
<term>Prospective Studies</term>
<term>Seasons</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Nouveau-né</term>
<term>Saisons</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Surveillance de la population</term>
<term>Études prospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The Global Influenza Hospital Surveillance Network (GIHSN) has established a prospective, active surveillance, hospital-based epidemiological study to collect epidemiological and virological data for the Northern and Southern Hemispheres over several consecutive seasons. It focuses exclusively on severe cases of influenza requiring hospitalization. A standard protocol is shared between sites allowing comparison and pooling of results. During the 2014-2015 influenza season, the GIHSN included seven coordinating sites from six countries (St. Petersburg and Moscow, Russian Federation; Prague, Czech Republic; Istanbul, Turkey; Beijing, China; Valencia, Spain; and Rio de Janeiro, Brazil). Here, we present the detailed epidemiological and influenza vaccine effectiveness findings for the Northern Hemisphere 2014-2015 influenza season.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
<PMID Version="1">27556802</PMID>
<DateCompleted>
<Year>2017</Year>
<Month>08</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>12</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1471-2458</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>16 Suppl 1</Volume>
<PubDate>
<Year>2016</Year>
<Month>08</Month>
<Day>22</Day>
</PubDate>
</JournalIssue>
<Title>BMC public health</Title>
<ISOAbbreviation>BMC Public Health</ISOAbbreviation>
</Journal>
<ArticleTitle>Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the Global Influenza Hospital Surveillance Network.</ArticleTitle>
<Pagination>
<MedlinePgn>757</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-016-3378-1</ELocationID>
<Abstract>
<AbstractText>The Global Influenza Hospital Surveillance Network (GIHSN) has established a prospective, active surveillance, hospital-based epidemiological study to collect epidemiological and virological data for the Northern and Southern Hemispheres over several consecutive seasons. It focuses exclusively on severe cases of influenza requiring hospitalization. A standard protocol is shared between sites allowing comparison and pooling of results. During the 2014-2015 influenza season, the GIHSN included seven coordinating sites from six countries (St. Petersburg and Moscow, Russian Federation; Prague, Czech Republic; Istanbul, Turkey; Beijing, China; Valencia, Spain; and Rio de Janeiro, Brazil). Here, we present the detailed epidemiological and influenza vaccine effectiveness findings for the Northern Hemisphere 2014-2015 influenza season.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Puig-Barberà</LastName>
<ForeName>Joan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Foundation for the Promotion of Health and Biomedical Research in the Valencia Region FISABIO - Public Health, Avda Catalunya 21, 46020, Valencia, Spain. puig_joa@gva.es.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Burtseva</LastName>
<ForeName>Elena</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>D.I. Ivanovsky Institute of Virology FGBC "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation, Russia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yu</LastName>
<ForeName>Hongjie</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cowling</LastName>
<ForeName>Benjamin J</ForeName>
<Initials>BJ</Initials>
<AffiliationInfo>
<Affiliation>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Special Administrative Region, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Badur</LastName>
<ForeName>Selim</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kyncl</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>National Institute of Public Health (NIPH), Prague, Czech Republic.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sominina</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Research Institute of Influenza, Saint Petersburg, Russian Federation, Russia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>GIHSN</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>08</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>BMC Public Health</MedlineTA>
<NlmUniqueID>100968562</NlmUniqueID>
<ISSNLinking>1471-2458</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001938" MajorTopicYN="N">Brazil</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002681" MajorTopicYN="N">China</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018153" MajorTopicYN="N">Czech Republic</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011159" MajorTopicYN="Y">Population Surveillance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012426" MajorTopicYN="N">Russia</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013030" MajorTopicYN="N">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014421" MajorTopicYN="N">Turkey</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">Epidemiological study</Keyword>
<Keyword MajorTopicYN="Y">Hospitalization</Keyword>
<Keyword MajorTopicYN="Y">Influenza</Keyword>
<Keyword MajorTopicYN="Y">Surveillance</Keyword>
<Keyword MajorTopicYN="Y">Vaccine</Keyword>
<Keyword MajorTopicYN="Y">Virus</Keyword>
</KeywordList>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Afanasieva</LastName>
<ForeName>Olga</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Afanasieva</LastName>
<ForeName>Veronica</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ciblak</LastName>
<ForeName>MeralAkcay</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Aktas</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Badur</LastName>
<ForeName>Selim</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Belenguer-Varea</LastName>
<ForeName>Ángel</ForeName>
<Initials>Á</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Borekci</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Boza</LastName>
<ForeName>Fernando</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bursteva</LastName>
<ForeName>Elena</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Buzitskaya</LastName>
<ForeName>Zhanna</ForeName>
<Initials>Z</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Caetano</LastName>
<ForeName>Braulia</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cai</LastName>
<ForeName>Jian</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Çakir</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Carballido-Fernández</LastName>
<ForeName>Mario</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Carbonell-Franco</LastName>
<ForeName>Empar</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Carratalá-Munuera</LastName>
<ForeName>Concha</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Çelebi</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chai</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>de Paula</LastName>
<ForeName>IvamaraChangas de Lima Porto</ForeName>
<Initials>Ide L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Enfu</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cowling</LastName>
<ForeName>Ben</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cui</LastName>
<ForeName>Yunjie</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Deniz</LastName>
<ForeName>D B</ForeName>
<Initials>DB</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dondurei</LastName>
<ForeName>Elena</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dong</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dong</LastName>
<ForeName>X</ForeName>
<Initials>X</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Durusu</LastName>
<ForeName>Mine</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>El Guerche-Séblain</LastName>
<ForeName>Clotilde</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Enda-Moura</LastName>
<ForeName>Fernanda</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Eren-Şensoy</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fadeev</LastName>
<ForeName>Artem</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Feng</LastName>
<ForeName>Luzhao</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Feng</LastName>
<ForeName>Shuo</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>César</LastName>
<ForeName>Raimundo</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fisch</LastName>
<ForeName>Patricia</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Garina</LastName>
<ForeName>Ekaterina</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gencer</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gil-Guillén</LastName>
<ForeName>Vicente</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Go</LastName>
<ForeName>Alexa</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gonchar</LastName>
<ForeName>Vitaly</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Golovacheva</LastName>
<ForeName>Ekaterina</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Grudinin</LastName>
<ForeName>Mikhail</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hacımustafaoğlu</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hancerli</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Havlickova</LastName>
<ForeName>Martina</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Herrmannova</LastName>
<ForeName>Kristyna</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jiang</LastName>
<ForeName>Hui</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ip</LastName>
<ForeName>Dennis</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jirincova</LastName>
<ForeName>Helena</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jurzykowska</LastName>
<ForeName>Lucie</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kisteneva</LastName>
<ForeName>Lidiya</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kolobukhina</LastName>
<ForeName>Ludmila</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Komissarov</LastName>
<ForeName>Andrey</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kralova</LastName>
<ForeName>Radka</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Krasnoslobotsev</LastName>
<ForeName>Kirill</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kyncl</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Labrador</LastName>
<ForeName>Xavier</ForeName>
<Initials>X</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Chao</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Xiangxin</ForeName>
<Initials>X</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Limón-Ramírez</LastName>
<ForeName>Ramón</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Jianhua</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Carmen</LastName>
<ForeName>Mari</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mahé</LastName>
<ForeName>Cédric</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mandakova</LastName>
<ForeName>Zdenka</ForeName>
<Initials>Z</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Merkulova</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mese</LastName>
<ForeName>Sevim</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Iglesias</LastName>
<ForeName>AinaraMira</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mukasheva</LastName>
<ForeName>Evgenia</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sancho</LastName>
<ForeName>AngelsNatividad</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nováková</LastName>
<ForeName>Lucia</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Obraztsova</LastName>
<ForeName>Elena</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Osidak</LastName>
<ForeName>Ludmila</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Del Carmen</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Özer</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ozisik</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Picot</LastName>
<ForeName>Valentina</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pisarev</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pradel</LastName>
<ForeName>Florence</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Prochazkova</LastName>
<ForeName>Jitka</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Puig-Barberá</LastName>
<ForeName>Joan</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Qin</LastName>
<ForeName>Ying</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Raboni</LastName>
<ForeName>Sonia</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Roháčová</LastName>
<ForeName>Hana</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rozhkova</LastName>
<ForeName>Elena</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Sa</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sadikhova</LastName>
<ForeName>M I</ForeName>
<Initials>MI</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Schwarz-Chavarri</LastName>
<ForeName>Germán</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Siqueira</LastName>
<ForeName>Marilda</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Smorodintseva</LastName>
<ForeName>Elizaveta</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sominina</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Stolyarov</LastName>
<ForeName>Kirill</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sukhovetskaya</LastName>
<ForeName>Vera</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sun</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tang</LastName>
<ForeName>Y</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tortajada-Girbés</LastName>
<ForeName>Miguel</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Trushakova</LastName>
<ForeName>Svetlana</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tuells</LastName>
<ForeName>José</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tumina</LastName>
<ForeName>Tatiana</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vartanyan</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Voloshuk</LastName>
<ForeName>Lubov</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Quanyi</ForeName>
<Initials>Q</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wen</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Peng</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Xiao</LastName>
<ForeName>Wen</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Peng</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yanina</LastName>
<ForeName>Marina</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yi</LastName>
<ForeName>Bo</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yu</LastName>
<ForeName>Hongjie</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yurtcu</LastName>
<ForeName>Kubra</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zarishnyuk</LastName>
<ForeName>Pavel</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Yi</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Tiebiano</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zheng</LastName>
<ForeName>Jiandong</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Peng</LastName>
<ForeName>Zhibin</ForeName>
<Initials>Z</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>8</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>8</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>8</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27556802</ArticleId>
<ArticleId IdType="doi">10.1186/s12889-016-3378-1</ArticleId>
<ArticleId IdType="pii">10.1186/s12889-016-3378-1</ArticleId>
<ArticleId IdType="pmc">PMC5001209</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2015 Feb 26;20(8):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25742432</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2015 Jan 29;20(4):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25655053</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Stat Med. 2002 Jun 15;21(11):1539-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12111919</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14001-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10570188</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Care Med. 2014 Nov;42(11):2325-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25148596</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Wkly Epidemiol Rec. 2015 Mar 13;90(11):97-108</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25771542</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2013 Mar;56(5):677-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23074315</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2016 May 19;11(5):e0154970</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27196667</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2013 Oct 15;208(8):1305-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23863950</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2013 Sep 13;31(40):4280-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23850417</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Wkly Epidemiol Rec. 2015 Jun 5;90(23):281-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26050269</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Influenza Other Respir Viruses. 2015 Jul 21;:null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26198771</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2014 Jun 19;9(6):e100497</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24945510</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2011 Jun 15;203(12):1739-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21606532</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2016;21(4):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26848118</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2015 May 15;211(10):1519-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25416812</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2003 Sep 6;327(7414):557-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12958120</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 2015 Aug 15;182(4):294-301</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26188191</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Public Health. 2014 Jun 05;14:564</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24903737</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23210147</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 2013 Sep 15;188(6):710-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23855650</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2013 Jun 26;31(30):3104-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23624093</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2011 Jul;8(7):e1001053</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21750667</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2016 Mar 8;34(11):1350-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26854911</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2015 Jan 16;64(1):10-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25590680</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Respir Med. 2014 Jun;2(6):445-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24717637</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2014 Jul 15;59(2):166-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24785230</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2010 Sep 15;202(6):881-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20677944</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2015 Feb 23;10(2):e0117716</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25706880</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2009 Aug;15(8):1271-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19751590</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Espagne</li>
<li>Russie</li>
<li>République populaire de Chine</li>
<li>République tchèque</li>
<li>Turquie</li>
</country>
<region>
<li>Bohême centrale</li>
</region>
<settlement>
<li>Prague</li>
<li>Pékin</li>
</settlement>
</list>
<tree>
<country name="Espagne">
<noRegion>
<name sortKey="Puig Barbera, Joan" sort="Puig Barbera, Joan" uniqKey="Puig Barbera J" first="Joan" last="Puig-Barberà">Joan Puig-Barberà</name>
</noRegion>
</country>
<country name="Russie">
<noRegion>
<name sortKey="Burtseva, Elena" sort="Burtseva, Elena" uniqKey="Burtseva E" first="Elena" last="Burtseva">Elena Burtseva</name>
</noRegion>
<name sortKey="Sominina, Anna" sort="Sominina, Anna" uniqKey="Sominina A" first="Anna" last="Sominina">Anna Sominina</name>
</country>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Yu, Hongjie" sort="Yu, Hongjie" uniqKey="Yu H" first="Hongjie" last="Yu">Hongjie Yu</name>
</noRegion>
<name sortKey="Cowling, Benjamin J" sort="Cowling, Benjamin J" uniqKey="Cowling B" first="Benjamin J" last="Cowling">Benjamin J. Cowling</name>
</country>
<country name="Turquie">
<noRegion>
<name sortKey="Badur, Selim" sort="Badur, Selim" uniqKey="Badur S" first="Selim" last="Badur">Selim Badur</name>
</noRegion>
</country>
<country name="République tchèque">
<region name="Bohême centrale">
<name sortKey="Kyncl, Jan" sort="Kyncl, Jan" uniqKey="Kyncl J" first="Jan" last="Kyncl">Jan Kyncl</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000138 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000138 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeEspagneV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:27556802
   |texte=   Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the Global Influenza Hospital Surveillance Network.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:27556802" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeEspagneV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Fri Sep 25 11:01:38 2020. Site generation: Sat Feb 13 17:38:04 2021